Management of acute and chronic episodes of reversible bronchoconstriction. Goal of therapy is to treat acute attacks (short-term control) and to ↓ incidence and intensity of future attacks (long-term control). The choice of modalities depends on the continued requirement for short term control agents.
There's more to see -- the rest of this topic is available only to subscribers.
Vallerand, April Hazard., et al. "Antiasthmatics." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50909/9/antiasthmatics.
Vallerand AHA, Sanoski CAC, Quiring CC. Antiasthmatics. Davis's Drug Guide. F.A. Davis Company; 2023. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50909/9/antiasthmatics. Accessed June 7, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Antiasthmatics. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50909/9/antiasthmatics
Vallerand AHA, Sanoski CAC, Quiring CC. Antiasthmatics [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 June 07]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50909/9/antiasthmatics.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - antiasthmatics ID - 50909 A1 - Sanoski,Cynthia A, AU - Vallerand,April Hazard, AU - Quiring,Courtney, BT - Davis's Drug Guide UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/50909/9/antiasthmatics PB - F.A. Davis Company ET - 18 DB - Nursing Central DP - Unbound Medicine ER -